Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Huanli Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4599-9271; OpenAlex author ID A5101697187. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper

Papers 4

  1. Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo. Co-author DOI 10.2147/dddt.s265423↗
  2. Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR Pathway. First author DOI 10.3389/fphar.2019.00319↗
  3. Maslinic acid induces autophagy by down-regulating HSPA8 in pancreatic cancer cells. First author DOI 10.1002/ptr.6064↗
  4. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer. Co-author DOI 10.3748/wjg.v20.i34.12171↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiukun Lin · 3 shared papers, 2018–2020 · strength 0.29
  2. Ammad Ahmad Farooqı · 2 shared papers, 2018–2019 · strength 0.17
  3. Ling Zuo · 1 shared paper, 2020 · strength 0.11
  4. Xiao Li · 1 shared paper, 2019 · strength 0.10
  5. Ye Tian · 1 shared paper, 2018 · strength 0.07
  6. Xiaoliang Chen · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.